Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating

NCT02487550 is registered in ClinicalTrials.gov with The First People's Hospital of Changzhou as lead sponsor.

NCT NCT02487550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02487550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating
Lead sponsor
The First People's Hospital of Changzhou
Phase
Phase 2
Overall status
Not yet recruiting
Start date
August 31, 2015
Completion date
July 31, 2030
Enrollment
1,200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

renal neoplasma